# Rational Design of Recombinant Proteins ## Quick Answer - Rational protein design uses computational prediction and targeted mutagenesis to alter protein function with a structured decision pathway from sequence analysis to experimental validation. - The practical next step is selecting a validated computational tool for mutation effect prediction, then designing point mutations with silent restriction sites for efficient cloning. - A critical limitation is that computational predictions require experimental confirmation through expression, purification, and functional assays before any engineered variant is considered reliable. ## At a Glance | Design Stage | Primary Decision | Key Tool or Method | Validation Requirement | |---|---|---|---| | Sequence Analysis | Identify conserved residues and functional domains | Multiple sequence alignment, structural databases | Confirm target residue is conserved across homologs | | Mutation Selection | Choose point mutation vs. domain swap | Computational prediction tools, Rosetta, FoldX | Predict stability and binding effects before cloning | | Cloning Strategy | Select restriction sites or Gibson assembly | Primer design, plasmid maps | Verify insert orientation and sequence by Sanger sequencing | | Expression Testing | Choose host system and induction conditions | E. coli, yeast, or mammalian expression | Confirm soluble protein production by SDS-PAGE | | Functional Validation | Design activity or binding assay | Enzymatic assay, surface plasmon resonance | Compare mutant activity to wild-type control | | Data Reporting | Document all parameters and controls | MIQE-style reporting for qPCR, assay metadata | Ensure reproducibility through complete methods | ## Understanding Rational Protein Design Rational protein design is a systematic approach to modifying protein structure and function through targeted mutations based on structural knowledge and computational analysis. This method contrasts with directed evolution, which relies on random mutagenesis and selection. The rational approach requires researchers to understand the relationship between amino acid sequence, three-dimensional structure, and biological function. The foundation of rational design rests on the principle that specific amino acid changes produce predictable structural and functional consequences. Researchers use structural biology data from X-ray crystallography, cryo-electron microscopy, or nuclear magnetic resonance spectroscopy to identify residues that participate in catalysis, ligand binding, or protein-protein interactions. The design process begins with a clear question about which property needs alteration, such as increasing thermostability, changing substrate specificity, or improving binding affinity. The structured approach to rational design follows a logical progression from sequence analysis to functional validation. Each stage requires specific computational tools and experimental methods. The process demands careful record keeping and systematic evaluation of results at every step. Researchers must document their design rationale, computational predictions, and experimental outcomes to build a reliable knowledge base for future engineering efforts. The field has matured significantly with advances in computational power and structural databases. Modern design workflows integrate multiple prediction algorithms with experimental feedback loops. The success of a rational design project depends on the quality of the starting structural information, the accuracy of computational predictions, and the sensitivity of the validation assays. ## Core Principles of Protein Structure and Function ### The Relationship Between Sequence and Structure The amino acid sequence of a protein determines its three-dimensional structure, which in turn determines its function. This fundamental relationship forms the basis of rational protein design. The sequence of amino acids folds into a specific structure through a combination of hydrogen bonding, hydrophobic interactions, electrostatic forces, and van der Waals contacts. The structural organization of proteins occurs at multiple levels. The primary structure is the linear amino acid sequence. The secondary structure includes alpha helices and beta sheets that form through local hydrogen bonding patterns. The tertiary structure is the overall three-dimensional fold of a single polypeptide chain. The quaternary structure describes the assembly of multiple polypeptide chains into a functional complex. The relationship between sequence and structure is complex because many different sequences can fold into similar structures. This degeneracy means that a researcher can introduce mutations that preserve the overall fold while altering specific functional properties. The challenge is identifying which positions can tolerate substitution without disrupting the structural integrity of the protein. ### Structural Motifs and Functional Domains Proteins contain structural motifs and functional domains that serve specific roles. A domain is a region of the protein that folds independently and often carries a specific function. Common domains include catalytic domains, binding domains, and regulatory domains. The modular nature of proteins allows researchers to design changes within a specific domain without affecting the rest of the protein. The active site of an enzyme is a specialized region that binds substrates and catalyzes chemical reactions. The active site contains residues that are directly involved in catalysis and residues that contribute to substrate binding. The design of mutations in the active site requires careful consideration of the catalytic mechanism and the structural constraints of the binding pocket. The substrate specificity of an enzyme is determined by the shape and chemical properties of the binding pocket. Changing the substrate specificity requires modifying the residues that line the binding pocket to accommodate a different substrate. This type of design requires detailed knowledge of the enzyme structure and the substrate interactions. ### Computational Tools for Structure Prediction Computational tools have become essential for predicting the effects of mutations on protein structure and function. These tools use different approaches to estimate the consequences of amino acid substitutions. Some tools use statistical analysis of known protein structures, while others use physics-based energy calculations. The choice of computational tool depends on the specific design question. Some tools are better suited for predicting the effects of mutations on protein stability, while others are better for predicting effects on binding affinity. The researcher must understand the strengths and limitations of each tool to interpret the predictions correctly. The accuracy of computational predictions depends on the quality of the input structure. A high-resolution crystal structure provides a better starting point than a low-resolution model. The researcher must also consider the flexibility of the protein and the potential for conformational changes upon mutation. ## Designing Point Mutations for Functional Alteration ### Identifying Target Residues The first step in designing a point mutation is identifying the residue that is most likely to affect the desired property. This identification requires a thorough analysis of the protein structure and function. The researcher should examine the active site, binding pockets, and other functional regions to identify residues that are directly involved in the function of interest. The sequence conservation across homologous proteins provides valuable information about which residues are important. Highly conserved residues are likely to be critical for structure or function, while variable residues may tolerate substitution. The researcher should align the target protein with related proteins to identify conserved regions and residues. The structural context of a residue is also important. A residue that is buried in the hydrophobic core of the protein may be important for stability, while a surface residue may be important for interactions with other molecules. The researcher should consider the solvent accessibility of the residue and its position in the three-dimensional structure. ### Choosing the Amino Acid Substitution The choice of the amino acid substitution depends on the desired effect. The researcher must consider the chemical properties of the amino acid, including size, charge, hydrophobicity, and hydrogen-bonding potential. The substitution should be designed to achieve the desired functional change while minimizing the disruption to the overall structure. For example, changing a residue in the active site of an enzyme can alter the substrate specificity. A residue that is involved in substrate binding can be changed to a different amino acid to accommodate a different substrate. The researcher must consider the size and chemical properties of the new amino acid to ensure that it can interact with the new substrate. The substitution should also be designed to avoid introducing unfavorable interactions. A mutation that introduces a charged residue into a hydrophobic pocket may destabilize the protein. The researcher should use computational tools to predict the effects of the mutation on protein stability before proceeding with the experimental work. ### Designing the Mutagenesis Strategy The mutagenesis strategy describes how the mutation will be introduced into the gene. The most common method is site-directed mutagenesis, which uses a primer with the desired mutation to amplify the plasmid. The primer is designed to introduce the mutation while maintaining the rest of the sequence. The design of the mutagenesis primer is critical for the success of the experiment. The primer should have a melting temperature that is appropriate for the polymerase used. The mutation should be placed in the middle of the primer with sufficient flanking sequence on both sides to ensure proper annealing. The primer should also be designed to avoid secondary structures that could interfere with the reaction. The choice of the mutagenesis method depends on the specific application. Some methods use a single primer, while others use two complementary primers. The researcher should select the method that is most reliable for the specific gene and mutation. The success of the mutagenesis should be confirmed by sequencing the entire gene to ensure that no unintended mutations have been introduced. ## Computational Tools for Predicting Mutation Effects ### Overview of Prediction Tools The computational prediction of mutation effects has become an essential part of rational protein design. These tools use different approaches to predict the consequences of a mutation on protein stability, function, and interactions. The choice of tool depends on the specific design question and the available structural information. The prediction tools can be divided into several categories. Sequence-based tools use the sequence of the protein to predict the effects of mutations. Structure-based tools use the three-dimensional structure of the protein to calculate the energetic consequences of a mutation. Hybrid tools combine sequence and structure information to improve the accuracy of the predictions. The accuracy of the prediction tools varies depending on the specific mutation and the protein. The researcher should use multiple tools to cross-validate the predictions and should consider the predictions as a guide instead of a detailed explanation. The predictions should be confirmed experimentally before the mutation is considered successful. ### Using Prediction Tools in the Design Process The prediction tools should be used at the design stage to evaluate the potential effects of a mutation before the experimental work begins. The researcher should use the tools to compare the effects of different mutations and to select the mutation that is most likely to achieve the desired functional change. The prediction tools can also be used to identify residues that are likely to be important for the function of interest. The researcher can use the tools to scan the entire protein for residues that are likely to affect the function. This approach can identify residues that may not be obvious from the structural analysis alone. The prediction tools should be used in combination with the structural analysis. The researcher should consider the structural context of the mutation in addition to the computational prediction. The combination of structural analysis and computational prediction provides a more reliable basis for the design than either approach alone. ### Limitations of Computational Prediction The computational prediction of mutation effects has several limitations. The prediction tools are based on models that may not capture all of the complexity of protein structure and function. The predictions are often based on the assumption that the protein structure does not change upon mutation, which may not be true. The prediction tools may not account for the effects of the mutation on protein dynamics. The protein is a dynamic molecule that can adopt multiple conformations. The mutation may affect the dynamics of the protein in ways that are not captured by the prediction tools. The prediction tools also may not account for the effects of the mutation on protein-protein interactions. The mutation may affect the ability of the protein to interact with other molecules, which may not be captured by the prediction tools. The researcher should consider these limitations when interpreting the predictions. ## Experimental Validation of Engineered Variants ### Expression and Purification of the Variant The first step in the experimental validation of an engineered variant is the expression and purification of the protein. The gene encoding the variant is cloned into an expression vector and introduced into a host cell. The host cell is then cultured under conditions that induce the expression of the protein. The choice of the expression system depends on the protein and the intended use. The most common expression system is E. coli, which is easy to culture and can produce large amounts of protein. However, some proteins require a eukaryotic expression system for proper folding and post-translational modifications. The researcher should choose the expression system that is most appropriate for the specific protein. The purification of the protein involves a series of steps to isolate the protein from the other components of the cell. The purification strategy depends on the properties of the protein, such as its size, charge, and hydrophobicity. The researcher should use a purification strategy that yields a pure protein with the desired activity. ### Functional Assays for the Variant The functional validation of the engineered variant requires a functional assay that measures the specific property that was designed. The assay should be designed to measure the activity of the protein in a quantitative way. The assay should also be designed to be sensitive enough to detect the changes in activity that are expected from the mutation. The choice of the functional assay depends on the function of the protein. For an enzyme, the assay may measure the rate of the reaction. For a binding protein, the assay may measure the affinity of the protein for its ligand. The researcher should choose an assay that is appropriate for the specific function of the protein. The functional assay should be performed with the wild-type protein as a control. The activity of the variant should be compared to the activity of the wild-type protein to determine the effect of the mutation. The assay should also be performed with multiple replicates to ensure that the results are reproducible. ### Confirming the Structure of the Variant The functional validation of the engineered variant should also include a confirmation of the structure of the protein. The mutation may have unintended effects on the structure of the protein, which could affect the function. The researcher should use structural methods to confirm that the protein has the expected structure. The most common method for confirming the structure of a protein is X-ray crystallography. This method requires the protein to be crystallized, which can be difficult for some proteins. Other methods, such as cryo-electron microscopy or NMR spectroscopy, can also be used to determine the structure of the protein. The structural confirmation should be performed if the functional assay shows an unexpected result. The structural analysis can help to explain the unexpected result and can guide the design of the next round of mutations. The structural confirmation is also important for the validation of the design. ## Molecular Cloning and Recombinant DNA Methods ### Plasmid Cloning and Vector Design The design of the plasmid vector is a critical step in the molecular cloning of the engineered gene. The vector must contain the elements that are necessary for the expression of the gene in the host cell. The vector must also contain a selectable marker that allows the researcher to identify the cells that have taken up the vector. The choice of the vector depends on the expression system and the intended use of the protein. The vector may contain a promoter that drives the expression of the gene, a terminator that stops the transcription, and a selectable marker that confers resistance to an antibiotic. The vector may also contain a tag that facilitates the purification of the protein. The design of the vector should be done using a computer program that allows the researcher to plan the cloning strategy. The researcher should consider the restriction sites that are available in the vector and the gene. The researcher should also consider the reading frame of the gene to ensure that the protein is expressed correctly. ### DNA Assembly Methods The assembly of the engineered gene into the plasmid vector can be done using several methods. The most common method is restriction enzyme digestion and ligation. This method uses restriction enzymes to cut the vector and the gene at specific sites, and then ligates the gene into the vector. The choice of the DNA assembly method depends on the specific requirements of the cloning. The restriction enzyme digestion and ligation method is simple and reliable, but it requires the presence of restriction sites in the gene and the vector. The Gibson assembly method is a more flexible method that does not require restriction sites, but it requires the design of specific primers. The DNA assembly method should be chosen based on the specific requirements of the cloning. The researcher should consider the size of the gene, the availability of restriction sites, and the desired efficiency of the cloning. The researcher should also consider the cost and the time required for the method. ### Confirming the Cloned Gene The confirmation of the cloned gene is essential to ensure that the correct sequence has been inserted into the vector. The confirmation is typically done by sequencing the entire gene. The sequencing should be done to confirm that the mutation has been introduced correctly and that no unintended mutations have been introduced. The sequencing should be done with a primer that is specific to the gene or the vector. The sequencing should be done in both directions to ensure that the entire gene is covered. The sequencing results should be compared to the expected sequence to confirm that the cloning was successful. The confirmation of the cloned sequence is also important for the reproducibility of the experiment. The researcher should record the sequence of the cloned gene and the details of the cloning procedure. This record will allow the researcher to reproduce the cloning in the future and to share the information with other researchers. ## Quality Control and Reproducibility ### The Importance of Controls The use of appropriate controls is essential for the reliability of the experimental results. The controls should be designed to account for the potential sources of variation in the experiment. The controls should also be designed to allow the researcher to distinguish the effects of the mutation from the effects of the experimental procedure. The most important control is the wild-type protein. The wild-type protein should be expressed, purified, and assayed under the same conditions as the variant. The activity of the variant should be compared to the activity of the wild-type protein to determine the effect of the mutation. The controls should also include a negative control that does not contain the protein. The negative control should be used to account for the background activity in the assay. The negative control should be included in the assay to ensure that the measured activity is due to the protein and not to the other components of the assay. ### Record Keeping and Documentation The documentation of the experimental procedures and results is essential for the reproducibility of the experiment. The researcher should record the details of the design, the cloning, the expression, the purification, and the functional assay. The researcher should also record the results of the experiment, including the raw data and the analysis. The documentation should be done in a way that allows the researcher to reproduce the experiment in the future. The researcher should record the exact conditions of the experiment, including the temperature, the time, and the concentrations of the reagents. The researcher should also record the lot numbers of the reagents and the equipment used. The documentation should also be done in a way that allows other researchers to understand the experiment. The researcher should describe the rationale for the design and the interpretation of the results. The documentation should be clear and complete, and it should be written in a way that is accessible to other researchers. ### Reproducibility and Transparency The reproducibility of the experimental results is a key requirement for the validity of the design. The researcher should be able to reproduce the results of the experiment in a separate experiment. The researcher should also be able to reproduce the results in a different laboratory. The reproducibility of the experiment depends on the quality of the documentation and the standardization of the procedures. The researcher should use standardized procedures and reagents to ensure that the results are reproducible. The researcher should also use the same equipment and the same conditions for the experiment. The transparency of the experimental procedures is also important for the reproducibility of the results. The researcher should report the details of the experimental procedures and the results in a way that is transparent and accessible. The researcher should also report the limitations of the experiment and the potential sources of error. ## Biosafety and Regulatory Considerations ### Biosafety Principles for Recombinant DNA Work The work with recombinant DNA molecules requires adherence to biosafety principles to protect the researcher and the environment. The biosafety principles are designed to prevent the accidental release of recombinant organisms and to prevent the exposure of the researcher to hazardous materials. The biosafety principles are based on the risk assessment of the specific experiment. The risk assessment considers the properties of the host organism, the vector, and the inserted gene. The risk assessment also considers the potential for the recombinant organism to cause harm to the researcher or the environment. The biosafety principles are implemented through the use of containment measures. The containment measures include the use of biological safety cabinets, the use of personal protective equipment, and the use of appropriate waste disposal procedures. The containment measures are designed to prevent the release of the recombinant organisms into the environment. ### Institutional Oversight and Compliance The research involving recombinant DNA molecules is subject to institutional oversight. The institution is responsible for ensuring that the research is conducted in a safe and compliant manner. The institution is also responsible for ensuring that the research is conducted in accordance with the applicable regulations and guidelines. The institutional oversight is typically provided by the Institutional Biosafety Committee. The committee is responsible for reviewing the research proposals and for ensuring that the research is conducted in a safe and compliant manner. The committee is also responsible for the biosafety training of the researchers. The researcher should be aware of the institutional oversight requirements and should comply with the requirements. The researcher should submit the research proposal to the committee for review before the research is conducted. The researcher should also comply with the recommendations of the committee. ### Guidelines for Recombinant Nucleic Acid Research The research involving recombinant nucleic acid molecules is subject to the guidelines that are established by the National Institutes of Health. The guidelines are designed to ensure that the research is conducted in a safe and compliant manner. The guidelines are also designed to ensure that the research is conducted in accordance with the applicable regulations. The guidelines describe the containment measures that are required for the different types of experiments. The guidelines also describe the responsibilities of the researcher and the institution. The researcher should be familiar with the guidelines and ensure that the research is conducted in accordance with the guidelines. The guidelines are updated periodically to reflect the advances in the field. The researcher should be aware of the updates to the guidelines and ensure that the research is conducted in accordance with the latest version of the guidelines. The researcher should also be aware of the institutional requirements that may be more stringent than the guidelines. ## Common Failure Patterns and Troubleshooting ### Failure of the Mutagenesis The failure of the mutagenesis is a common problem in the rational design of proteins. The mutagenesis may fail to introduce the desired mutation, or the mutagenesis may introduce unintended mutations. The failure of the mutagenesis can be caused by several factors, including the design of the primer, the conditions of the reaction, and the quality of the template. The troubleshooting of the mutagenesis failure should begin with the design of the primer. The primer should be designed to have the appropriate melting temperature and to avoid the formation of secondary structures. The primer should also be designed to have the mutation in the correct position and to have the appropriate flanking sequence. The troubleshooting should also consider the conditions of the reaction. The reaction should be performed with the appropriate polymerase and the appropriate buffer. The reaction should also be performed with the appropriate temperature and the appropriate number of cycles. The troubleshooting should also consider the quality of the template, which should be pure and free of contaminants. ### Failure of the Expression The failure of the expression of the engineered variant is another common problem. The expression may fail to produce the protein, or the expression may produce the protein in an insoluble form. The failure of the expression can be caused by several factors, including the choice of the expression system, the design of the vector, and the conditions of the culture. The troubleshooting of the expression failure should begin with the choice of the expression system. The protein may not be expressed in the chosen host, or the protein may be expressed in an insoluble form. The researcher should consider the use of a different expression system or the use of a different vector. The troubleshooting should also consider the conditions of the culture. The expression may be improved by changing the temperature, the induction time, or the concentration of the inducer. The troubleshooting should also consider the design of the vector, including the promoter and the tag. ### Failure of the Functional Assay The failure of the functional assay to detect the expected activity is a common problem. The assay may not be sensitive enough to detect the activity, or the assay may not be appropriate for the specific protein. The failure of the functional assay can be caused by several factors, including the design of the assay, the conditions of the assay, and the quality of the protein. The troubleshooting of the functional assay failure should begin with the design of the assay. The assay should be designed to measure the specific activity of the protein. The assay should also be designed to be sensitive enough to detect the changes in the activity. The troubleshooting should also consider the conditions of the assay. The assay should be performed under the appropriate conditions, including the temperature, the pH, and the concentration of the substrate. The troubleshooting should also consider the quality of the protein, as the protein may be inactive or may be degraded. ## Limitations and Professional Escalation ### Limitations of the Rational Design The rational design of proteins has several limitations. The design is based on the available structural and functional information, which may be incomplete. The design may not account for the complexity of the protein structure and function, and the design may not be successful in achieving the desired functional change. The limitations of the rational design should be considered when interpreting the results of the experiment. The researcher should not expect the design to be successful in every case. The researcher should also consider the possibility that the design may have unintended effects on the protein. The limitations of the rational design should also be considered when planning the experiment. The researcher should consider the possibility that the design may not be successful and should plan for the possibility of the failure. The researcher should also consider the possibility that the design may require multiple rounds of mutation and validation. ### When to Escalate to a Specialist The rational design of proteins can be a complex process that requires specialized knowledge and skills. The researcher may need to escalate the design to a specialist if the design is not successful or if the design requires specialized expertise. The researcher should escalate the design to a specialist if the design is not successful after multiple rounds of mutation and validation. The specialist may be able to provide a different perspective on the design and may be able to identify the problems with the design. The researcher should also escalate the design to a specialist if the design requires specialized expertise, such as the use of advanced computational tools or the use of specialized experimental techniques. The specialist may be able to provide the expertise that is needed to complete the design. ### The Role of the Institutional Biosafety Committee The institutional biosafety committee plays an important role in the rational design of proteins. The committee is responsible for the oversight of the research and for ensuring that the research is conducted in a safe and compliant manner. The committee is also responsible for the review of the research proposals and for the recommendations for the safe conduct of the research. The researcher should consult with the institutional biosafety committee before the research is conducted. The researcher should submit the research proposal to the committee for review and should comply with the recommendations of the committee. The researcher should also consult with the committee if the research is changed or if the research is not successful. The institutional biosafety committee is also responsible for the training of the researchers. The committee should provide the training that is needed for the researchers to conduct the research in a safe and compliant manner. The committee should also provide the training that is needed for the researchers to understand the guidelines and the regulations. ## Frequently Asked Questions ### What is the difference between rational protein design and directed evolution? Rational protein design uses structural knowledge and computational tools to introduce specific mutations, while directed evolution uses random mutagenesis and selection to evolve proteins with desired properties. Rational design requires detailed structural information and a clear understanding of the structure-function relationship, whereas directed evolution does not require this knowledge but requires a robust selection or screening system. ### How do I choose the right computational tool for predicting mutation effects? The choice of computational tool depends on the specific design question and the available structural information. Structure-based tools are preferred when a high-resolution structure is available, while sequence-based tools can be used when the structure is not known. The researcher should use multiple tools to cross-validate the predictions and should consider the predictions as a guide instead of a detailed explanation. ### What is the most reliable method for introducing point mutations? The most reliable method for introducing point mutations is site-directed mutagenesis using a primer that contains the desired mutation. The primer should be designed with the mutation in the center and with appropriate flanking sequence for proper annealing. The success of the mutagenesis should be confirmed by sequencing the entire gene to ensure that no unintended mutations have been introduced. ### How do I confirm that my engineered variant has the desired structure? The structure of the engineered variant can be confirmed using X-ray crystallography, cryo-electron microscopy, or NMR spectroscopy. These methods require the protein to be purified and, in the case of crystallography, crystallized. The structural confirmation is important to ensure that the mutation has not disrupted the overall structure of the protein. ### What are the most common reasons for the failure of a rational design? The most common reasons for the failure of a rational design are the inaccurate prediction of the mutation effects, the disruption of the protein structure, and the unintended effects of the mutation on the protein function. The failure can also be caused by the experimental issues, such as the failure of the expression or the failure of the functional assay. ### How do I ensure the reproducibility of my experimental results? The reproducibility of the experimental results can be ensured by the use of standardized procedures, the documentation of the experimental details, and the use of appropriate controls. The researcher should record the exact conditions of the experiment and should use the same conditions for the replicate experiments. The researcher should also report the details of the experiment in a transparent way. ### What are the biosafety considerations for the rational design of proteins? The biosafety considerations for the rational design of proteins include the risk assessment of the experiment, the use of appropriate containment measures, and the compliance with the institutional oversight requirements. The researcher should be aware of the biosafety principles and should ensure that the research is conducted in a safe and compliant manner. ### When should I consult a specialist for my protein design project? The researcher should consult a specialist if the design is not successful after multiple rounds of attempts or if the design requires specialized expertise, such as advanced computational techniques or specialized experimental methods. The specialist can provide a different perspective on the design and can help identify the issues that are causing the failure. ## Using the Evidence | Source | Best use in this topic | Important limitation | |---|---|---| | [Molecular Biology and Laboratory Methods](https://www.ncbi.nlm.nih.gov/books) | official guidance | Check the linked page for current local requirements | | [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html) | official guidance | Check the linked page for current local requirements | | [NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules](https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules) | official guidance | Check the linked page for current local requirements | ## Related Molecular Biology Guides - [Recombinant Protein Definition: How Scientists Engineer Proteins](/knowledge/molecular-biology/recombinant-protein-definition) - [Contract Recombinant Protein Expression: A Comprehensive Guide](/knowledge/molecular-biology/contract-recombinant-protein-expression) - [Custom Recombinant Protein Expression: A Practical Guide](/knowledge/molecular-biology/custom-recombinant-protein-expression) - [How to Express Recombinant Protein: A Step-by-Step Guide](/knowledge/molecular-biology/express-recombinant-protein) - [Recombinant MICB Protein Expression: A Practical Guide](/knowledge/molecular-biology/recombinant-micb-protein-expression) ## References and Further Reading - [Molecular Biology and Laboratory Methods](https://www.ncbi.nlm.nih.gov/books). National Library of Medicine. - [Biosafety in Microbiological and Biomedical Laboratories](https://www.cdc.gov/labs/bmbl/index.html). CDC and NIH. - [NIH Guidelines for Recombinant or Synthetic Nucleic Acid Molecules](https://osp.od.nih.gov/policies/biosafety-and-biosecurity-policy/nih-guidelines-for-research-involving-recombinant-or-synthetic-nucleic-acid-molecules). National Institutes of Health. - [Addgene Protocols](https://www.addgene.org/protocols). Addgene. - [MIQE Guidelines](https://academic.oup.com/clinchem/article/55/4/611/5631762). Clinical Chemistry. - [NIST Laboratory Programs](https://www.nist.gov/laboratories). National Institute of Standards and Technology. - [Rational design of small-molecule responsive protein switches.](https://pubmed.ncbi.nlm.nih.gov/37656809). Protein science : a publication of the Protein Society, 2023. - [Rational modulator design by exploitation of protein-protein complex structures.](https://pubmed.ncbi.nlm.nih.gov/31141413). Future medicinal chemistry, 2019. - [A Brief History of De Novo Protein Design: Minimal, Rational, and Computational.](https://pubmed.ncbi.nlm.nih.gov/34298061). Journal of molecular biology, 2021. - [Rational Design and Synthesis of Peptide-Based Probes for Fibroblast Activation Protein-Targeted Magnetic Resonance and NIR-I/II Fluorescence Imaging of Cancer-Associated Fibroblasts.](https://pubmed.ncbi.nlm.nih.gov/40653873). Analytical chemistry, 2025. - [Rational design of elastin-like polypeptide fusion proteins to tune self-assembly and properties of protein vesicles.](https://pubmed.ncbi.nlm.nih.gov/37357544). Journal of materials chemistry. B, 2023. > This article is educational and does not replace validated laboratory procedures, institutional biosafety review, manufacturer instructions, or professional interpretation.